Source: Health Canada shortage reports · Updated Jul 10, 2026
Some Semaglutide products are in shortage in Canada (2 of 7 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
A GLP-1 medication used to treat type 2 diabetes and support weight management.
Products affected
2 / 7
In shortage since
Jun 2, 2026
Reports on file
10
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
RYBELSUS
7MG · TABLET · NOVO NORDISK CANADA INC
DIN 02497603 · since Jun 18, 2026, no end estimate
Active shortage
RYBELSUS
14MG · TABLET · NOVO NORDISK CANADA INC
DIN 02497611 · since Jun 2, 2026, no end estimate
Anticipated
SEMAGLUTIDE INJECTION
1.34MG · SOLUTION · DR REDDY'S LABORATORIES LTD
DIN 02567814 · Disruption of the manufacture of the drug.
Anticipated
SEMAGLUTIDE INJECTION
1.34MG · SOLUTION · DR REDDY'S LABORATORIES LTD
DIN 02567806 · Disruption of the manufacture of the drug.
Anticipated
RYBELSUS
3MG · TABLET · NOVO NORDISK CANADA INC
DIN 02497581
Resolved
OZEMPIC
1MG · SOLUTION · NOVO NORDISK CANADA INC
DIN 02471469 · ended Jan 17, 2024 · Demand increase for the drug.
Resolved
OZEMPIC
1.34MG · SOLUTION · NOVO NORDISK CANADA INC
DIN 02471477 · ended Feb 16, 2024 · Demand increase for the drug.
Resolved
RYBELSUS
3MG · TABLET · NOVO NORDISK CANADA INC
DIN 02497581 · ended Jan 9, 2024 · Delay in shipping of the drug.
Resolved
RYBELSUS
14MG · TABLET · NOVO NORDISK CANADA INC
DIN 02497611 · ended Jan 9, 2024 · Delay in shipping of the drug.
Resolved
OZEMPIC
1MG · SOLUTION · NOVO NORDISK CANADA INC
DIN 02471469 · ended Mar 24, 2023
What's happening
Semaglutide is currently affected by 2 active shortage reports filed with Health Canada by NOVO NORDISK CANADA INC.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Recent changes
Jul 10, 2026
New report filed
Jul 10, 2026
New report filed
Common questions
What is Semaglutide used for?
A GLP-1 medication used to treat type 2 diabetes and support weight management.
When will Semaglutide be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Semaglutide in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Possible alternatives in the same class
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.